Homologous cancerous cell membrane modulated multifunctional nanoshuttles: Targeting specificity and improved tumor theranostics

Yanru Cheng,Shuwei Liu,Lu Wang,Guojian Liu,Pin Zhao,Min Lin,Kunyan Sui,Hao Zhang

DOI: https://doi.org/10.1016/j.coco.2020.04.008

IF: 8

2020-08-01

Composites Communications

Abstract:<p>The short lifetime in blood circulation and unspecific uptake of positively charged nanocarriers shed doubt on in vivo applications. Herein, positive charged polyaniline nanoshuttles (Pani NSs) are modified with cancerous cell membranes (CCMs). The Pani NSs/CCMs composites maintain the magnetic resonance imaging (MRI) contrasting and photothermal converting performance in vivo. The CCMs modulation could mainly improve following aspects: 1) Improve the biocompatibility by depressing toxic release of Cu²⁺. 2) Increase the immune invisibility and the half-life (t_1/2) is prolonged from 4.0 to 13.8 h in blood circulation. 3) The homologous KB tumor targeting efficiency is dramatically enhanced from 3.2 to 11.5 %ID/g. However, elongated t_1/2 also reserves the non-homologous tumor uptake rate as 5.6 %ID/g, indicating insufficient targeting specificity of CCMs modulating strategy. This work gives deep understanding for the fundamental necessity of long lifetime in tumor uptake, which is prior to homologous targeting, and it signifies for the functional design and surface modification of nanoagents with enhanced theranostic performance.</p>

materials science, composites

What problem does this paper attempt to address?

The paper mainly addresses the following issues:

1. **Improving Biocompatibility**: By using cancer cell membranes (CCMs) to modify positively charged polyaniline nanoshuttles (Pani NSs), biocompatibility can be significantly improved, reducing the release of toxic copper ions (Cu²⁺).

2. **Extending Blood Circulation Time**: The modification with CCMs increases the half-life of the nanoshuttles in the blood from 4.0 hours to 13.8 hours, thereby enhancing the accumulation time and efficiency of nanoparticles at the tumor site.

3. **Enhancing Homologous Tumor Targeting**: The accumulation rate of Pani NSs modified with CCMs in homologous tumors (such as KB oral epithelial cancer) increased from 3.2% to 11.5%, thanks to the homologous recognition function of the proteins on the CCMs surface.

4. **Targeting Specificity in Multi-Tumor Systems**: Although CCMs modification can significantly improve the targeting of homologous tumors, the accumulation rate in non-homologous tumors in a multi-tumor system remains high (5.6% ID/g), indicating a lack of targeting specificity in this method.

5. **Understanding the Importance of Long Circulation for Tumor Uptake**: The study found that long circulation is fundamental to improving tumor uptake, taking precedence over homologous targeting. This means that even with good homologous targeting ability, long circulation remains one of the key factors for achieving efficient tumor treatment.

In summary, this paper demonstrates that the method of using CCMs to modify Pani NSs not only enhances the biocompatibility and tumor targeting of nanoparticles but also provides important insights into the relationship between targeting specificity and long circulation in the design of nanocarriers.